Once again it’s just a little (three billion dollars ) off the top for Glaxo as it settles yet another illegal marketing case with the federal government.
Three billion is no biggie for big pharma, and the tons of other pending cases against Glaxo (all of which it will settle for large sums) are also no biggie. Your med school colleagues will continue getting lucrative sales gigs for Glaxo while they’re researching Glaxo drugs, etc. All will again be well as soon as this latest thing settles down.